Joe Cohen

Research.com Recognitions

• 1999 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Best Publications

• A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

  J A Stoute;M Slaoui;D G Heppner;P Momin

  1345
  Citations

• First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

  Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar

  1235
  Citations

• Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

  Pedro L. Alonso;Jahit Sacarlal;John J. Aponte;Amanda J Leach

  1021
  Citations

• Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

  Kent E. Kester;James F. Cummings;Opokua Ofori-Anyinam;Christian F. Ockenhouse

  724
  Citations

• A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

  Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes

  717
  Citations

• Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

  Kalifa A. Bojang;Paul J. M. Milligan;Margaret Pinder;Laurence Vigneron

  690
  Citations

• Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

  Pedro L Alonso;Jahit Sacarlal;John J Aponte;Amanda Leach

  560
  Citations

• Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

  Philip Bejon;John Lusingu;Ally Olotu;Amanda Leach

  550
  Citations

• A field trial to assess a blood-Stage malaria vaccine

  Mahamadou A. Thera;Ogobara K. Doumbo;Drissa Coulibaly;Matthew B. Laurens

  443
  Citations

• Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.

  Bernhards R. Ogutu;Odika J. Apollo;Denise McKinney;Willis Okoth

  382
  Citations

• Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

  John J Aponte;John J Aponte;Pedro Aide;Montse Renom;Montse Renom;Inacio Mandomando

  353
  Citations

• Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

  Kent E. Kester;Denise A. McKinney;Nadia Tornieporth;Christian F. Ockenhouse

  353
  Citations

• A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.

  William H H Reece;Margaret Pinder;Philip K Gothard;Paul Milligan

  341
  Citations

• From the circumsporozoite protein to the RTS, S/AS candidate vaccine.

  Joe Cohen;Victor Nussenzweig;Ruth Nussenzweig;Johan Vekemans

  327
  Citations

• Long-Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

  J A Stoute;K E Kester;U Krzych;B T Wellde

  326
  Citations

• Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

  Salim Abdulla;Rolf Oberholzer;Rolf Oberholzer;Omar Juma;Sulende Kubhoja

  321
  Citations

• Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ

  Peifang Sun;Robert Schwenk;Katherine White;Jose A. Stoute

  301
  Citations

• Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

  D. Gray Heppner;Kent E. Kester;Christian F. Ockenhouse;Nadia Tornieporth

  257
  Citations

• Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

  Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta

  240
  Citations

• Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

  Jason A. Regules;Susan B. Cicatelli;Jason W. Bennett;Kristopher M. Paolino

  238
  Citations

• Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

  Ally Olotu;John Lusingu;John Lusingu;Amanda Leach;Marc Lievens

  232
  Citations